Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185440 · ClinicalTrials.gov registry record · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
A NA study of Sexual Violence and Drinking Heavy, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
- 1
- Study location
NCT05185440: Recruiting NA study of Sexual Violence and Drinking Heavy, sponsored by University of Pittsburgh.
NCT05185440 is a NA study of Sexual Violence and Drinking Heavy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 2,400 participants, above the 581-participant average among 10 other Sexual Violence trials with a reported enrollment target (313% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05185440, a NA study of Sexual Violence and Drinking Heavy, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
- 1
- Study location
Study Summary
This cluster-randomized controlled trial across 28+ college campuses focuses on undergraduate college students at elevated risk for sexual violence and hazardous drinking (i.e., students with prior history of sexual violence, students who are sexual or gender minority, and students with disabilities). "Reducing Alcohol Involved Sexual violence in higher Education (RAISE)" is a longitudinal study that will test research-informed strategies to improve implementation of a prevention intervention in college health and counseling centers, integrate a safety decision aid (via computer or mobile device) to more directly target harm reduction among students particularly vulnerable to hazardous drinking and SV, and evaluate campus policies that increase accessibility and uptake of confidential services for students. This is the first study to situate a sexual violence prevention intervention in college health and counseling centers to address two significant public health concerns -- alcohol-involved sexual violence and hazardous drinking on college campuses.
Primary Outcome
Yes to any items about SV and alcohol-involved SV talking points covered by provider during college health center visit (assessed in exit survey after visit)
Conditions Studied
Interventions
- BEHAVIORAL GIFTSS Training
- BEHAVIORAL Learning Collaborative
- BEHAVIORAL Provider Scripts
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05185440 shows while recruiting
NCT05185440 is an interventional study that assigns participants to a tested intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, above the 581-participant average among 10 other Sexual Violence trials with a reported enrollment target (313% higher).
The record links to 2 conditions, with Sexual Violence appearing as the primary indexed condition, and to 3 interventions - of which GIFTSS Training is the first listed.
NCT05185440 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05185440 about?
NCT05185440 is a clinical study titled "Reducing Alcohol Involved Sexual Violence in Higher Education". This cluster-randomized controlled trial across 28+ college campuses focuses on undergraduate college students at elevated risk for sexual violence and hazardous drinking (i.e., students with prior history of sexual violence, students who are sexual or gender minority, and students with disabilities...
What is the current status of trial NCT05185440?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,400 participants. The study started on 2023-06-12. Estimated completion is 2026-08.
What conditions does trial NCT05185440 study?
This clinical trial studies the following conditions: Sexual Violence, Drinking Heavy.
What interventions are being tested in trial NCT05185440?
The interventions under investigation include: GIFTSS Training (BEHAVIORAL), Learning Collaborative (BEHAVIORAL), Provider Scripts (BEHAVIORAL).
Who is sponsoring clinical trial NCT05185440?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05185440 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05185440's enrollment target sits among peer trials
2,400 2nd of 10 the highest of 10 other Sexual Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexual Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children
RECRUITING · NA
-
Collaborative Opportunities for Reducing Alcohol and Sexual Violence Together
RECRUITING · NA
-
Developing and Testing a Trauma-Informed Exercise Intervention for Women Veterans With Histories of Sexual Violence
RECRUITING · NA
-
Centering Gender Affirming Resources in Higher Education
RECRUITING · NA
-
Motivations, Attitudes, and Perceptions Study
RECRUITING · NA
-
Promoting Prosocial Bystander Behavior in Intoxicated Men: Evaluation of RealConsent2.0
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
- NCT05929768 · 2,400 participants · Phase 3
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI